Search
Migraine Paid Clinical Trials in New York
A listing of 29 Migraine clinical trials in New York actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
25 - 29 of 29
The state of New York currently has 29 active clinical trials seeking participants for Migraine research studies. These trials are conducted in various cities, including New York, Rochester, Bronx and Buffalo.
Featured Trial
Child/Teen Migraine Study
Recruiting
Sign up for a clinical trial today and contribute to the advancement of medical research, paving the way for innovative treatments. Receive financial compensation for your participation and benefit from complimentary medical care.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Migraine Clinical Trial
Recruiting
Migraine clinical trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Headache
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age
Recruiting
The primary objective of the study is to evaluate the effectiveness of fremanezumab as compared to placebo for the preventive treatment of chronic migraine (CM).
Secondary objectives are to further demonstrate the efficacy of Fremanezumab as compared to placebo for the preventive treatment of CM, to evaluate the safety and tolerability of Fremanezumab in the preventive treatment of CM and to evaluate the immunogenicity of Fremanezumab and the impact of antidrug antibodies (ADAs) on clinical out... Read More
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
02/28/2024
Locations: Teva Investigational Site 14276, Amherst, New York
Conditions: Migraine
NYU Langone Health Headache Center Learning Migraine Self-Management Techniques Study
Recruiting
The investigators aim to determine the feasibility of a migraine self-management program.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
02/26/2024
Locations: NYU Langone Health, New York, New York
Conditions: Migraine
Mi-Helper Transnasal Cooling for Acute Treatment of Migraine
Recruiting
This is a prospective, double-blind, sham-controlled, randomized two-part clinical trial with an adaptive design. This study aims to assess the efficacy, safety, tolerability, and the optimal dose of the Mi-Helper transnasal cooling device for acute treatment of migraine in an at home setting.
This study will be conducted in two parts. The first part of this study aims to determine the most effective dose of Mi-Helper and the second part aims to evaluate the efficacy, safety, and tolerability o... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
11/29/2023
Locations: ObvioHealth, New York, New York
Conditions: Episodic Migraine, Migraine With Aura, Migraine Without Aura, Migraine
RELAXaHEAD for Headache Patients (Phase III)
Recruiting
This study is a fully powered, remote randomized control trial to evaluate RELAXaHEAD in people with migraine.
Gender:
All
Ages:
Between 16 years and 80 years
Trial Updated:
11/06/2023
Locations: NYU Langone Health, New York, New York
Conditions: Migraine
An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants
Recruiting
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will how effective the combination use of ubrogepant and atogepant is in treating adult participants with migraine. Change in migraine activity will be assessed.
Urogepant (Ubrelvy) and Atogepant (Qulipta) are approved drugs for treatment of migraine in adults in the US. Approximately 432 adult participants who are prescribed Ubroge... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/02/2023
Locations: Montefiore/Albert Einstein /ID# 252243, Bronx, New York
Conditions: Migraine
25 - 29 of 29